Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating activities:      
Net income (loss) $ (44,038) $ 41,982 $ 67,936
Reconciliation of net income to net cash provided by (used in) operating activities:      
Depreciation and amortization 1,381 2,053 2,700
Goodwill impairment 2,884    
Stock-based compensation 1,407 1,205 1,021
Foreign currency transaction (gain) loss 0 17 (52)
Gain on CNS asset sale   (31,654)  
Gain on sale of ConferencePlus, net of tax   (20,489)  
(Gain) loss on sale or disposal of fixed assets (8) 18 2
Gain on sale of non-operating asset   (325)  
Restructuring 149 1,217  
Deferred taxes 29,865 12,438 (54,200)
Changes in assets and liabilities:      
Accounts receivable (979) 12,396 (6,426)
Inventory (2,002) 1,852 3,702
Prepaid expenses and other current assets (233) 1,002 1,132
Other assets (240) (265) 167
Deferred revenue (128) 336 (705)
Accounts payable and accrued expenses 23 (23,820) 8,522
Accrued compensation (206) (2,919) 436
Net cash provided by (used in) operating activities (12,125) (4,956) 24,235
Cash flows from investing activities:      
Maturities of held-to maturity short-term debt securities 16,817 8,352  
Maturities of other short-term investments 6,796 1,370 245
Purchases of held-to maturity short-term debt securities (29,090) (16,746)  
Purchases of other short-term investments (4,417) (6,941) (735)
Purchases of property and equipment (379) (819) (785)
Proceeds from sale of assets 15 325   
Proceeds from the sale of ConferencePlus, net of cash transferred   40,331  
Proceeds from CNS asset sale   36,729  
Payment for business acquisition (2,524)    
Changes in restricted cash 4,951 (7,451)  
Net cash provided by (used in) investing activities (7,831) 55,150 (1,275)
Cash flows from financing activities:      
Purchase of treasury stock (12,733) (17,385) (561)
Excess tax benefits from stock-based compensation   145  
Proceeds from stock options exercised 87 1,684 2,616
Repurchase of subsidiary stock options   (117) (36)
Net cash provided by (used in) financing activities (12,646) (15,673) 2,019
Effect of exchange rate changes on cash 3 (97) 114
Net increase (decrease) in cash and cash equivalents (32,599) 34,424 25,093
Cash and cash equivalents, beginning of period 120,832 86,408 61,315
Cash and cash equivalents, end of period 88,233 120,832 86,408
Supplemental Cash Flow Information      
Cash paid (refunded) for income taxes, net $ (524) $ 2,901 $ 874